loading
前日終値:
$18.50
開ける:
$18.17
24時間の取引高:
72,937
Relative Volume:
0.60
時価総額:
$164.50M
収益:
$123.24M
当期純損益:
$136.00K
株価収益率:
-935.00
EPS:
-0.02
ネットキャッシュフロー:
$-148.99M
1週間 パフォーマンス:
-1.53%
1か月 パフォーマンス:
+26.52%
6か月 パフォーマンス:
+39.53%
1年 パフォーマンス:
+14.07%
1日の値動き範囲:
Value
$17.82
$19.04
1週間の範囲:
Value
$17.82
$19.87
52週間の値動き範囲:
Value
$6.53
$26.40

Seres Therapeutics Inc Stock (MCRB) Company Profile

Name
名前
Seres Therapeutics Inc
Name
セクター
Healthcare (1154)
Name
電話
617 945 9626
Name
住所
200 SIDNEY STREET, CAMBRIDGE, MA
Name
職員
103
Name
Twitter
@SeresTX
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
MCRB's Discussions on Twitter

MCRB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MCRB
Seres Therapeutics Inc
18.79 170.89M 123.24M 136.00K -148.99M -0.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.60 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
568.91 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
451.88 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
733.58 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.27 36.53B 3.81B -644.79M -669.77M -6.24

Seres Therapeutics Inc Stock (MCRB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-08 ダウングレード Chardan Capital Markets Buy → Neutral
2024-10-24 ダウングレード JP Morgan Neutral → Underweight
2023-06-26 再開されました Oppenheimer Outperform
2023-04-21 開始されました JP Morgan Neutral
2021-07-23 ダウングレード Goldman Neutral → Sell
2021-05-18 再開されました Goldman Neutral
2021-03-05 アップグレード Chardan Capital Markets Neutral → Buy
2020-09-18 ダウングレード Chardan Capital Markets Buy → Neutral
2020-08-18 開始されました Piper Sandler Overweight
2020-08-11 繰り返されました H.C. Wainwright Buy
2020-08-11 アップグレード Jefferies Hold → Buy
2019-04-30 開始されました Jefferies Hold
2018-10-22 開始されました Chardan Capital Markets Buy
2017-10-13 開始されました Oppenheimer Outperform
2017-08-04 繰り返されました H.C. Wainwright Buy
2017-02-01 繰り返されました FBR & Co. Outperform
2016-08-12 繰り返されました FBR Capital Outperform
2016-08-01 ダウングレード BofA/Merrill Buy → Neutral
2016-08-01 繰り返されました H.C. Wainwright Buy
2016-07-29 再開されました H.C. Wainwright Buy
2016-03-30 開始されました FBR Capital Outperform
2016-03-03 開始されました Guggenheim Buy
2016-01-25 開始されました H.C. Wainwright Buy
2015-10-22 アップグレード BofA/Merrill Neutral → Buy
2015-07-22 開始されました Canaccord Genuity Buy
2015-07-21 開始されました Goldman Neutral
2015-07-21 開始されました Leerink Partners Outperform
すべてを表示

Seres Therapeutics Inc (MCRB) 最新ニュース

pulisher
Sep 03, 2025

Is Seres Therapeutics Inc. affected by consumer sentimentTrend Reversal & Weekly High Return Stock Opportunities - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Is now a turning point for Seres Therapeutics Inc.Market Movers & Growth Focused Stock Pick Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ranking Seres Therapeutics Inc. among high performing stocks via tools2025 Key Lessons & Safe Entry Trade Signal Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to read the order book for Seres Therapeutics Inc.Exit Point & Smart Investment Allocation Insights - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What machine learning models say about Seres Therapeutics Inc.July 2025 Breakouts & Technical Buy Zone Confirmations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What MACD signals say about Seres Therapeutics Inc.Gold Moves & Long-Term Growth Portfolio Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using Bollinger Bands to evaluate Seres Therapeutics Inc.2025 Stock Rankings & Safe Entry Trade Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Seres Therapeutics Inc. still worth holding after the dipDividend Hike & Stepwise Swing Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Statistical indicators supporting Seres Therapeutics Inc.’s strength2025 Support & Resistance & Stock Market Timing Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Seres Therapeutics Inc. stock outlook for YEARJuly 2025 Opening Moves & Reliable Trade Execution Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Evaluating Seres Therapeutics Inc. with trendline analysisWeekly Profit Recap & Free Long-Term Investment Growth Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Top chart patterns to watch in Seres Therapeutics Inc.July 2025 Review & Weekly Watchlist for Consistent Profits - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What is Seres Therapeutics Inc. s debt to equity ratioQuarterly Earnings Summary & Weekly Hot Stock Watchlists - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Tick level data insight on Seres Therapeutics Inc. volatilityJuly 2025 Review & Risk Controlled Stock Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What moving averages say about Seres Therapeutics Inc.July 2025 Market Mood & AI Forecasted Stock Moves - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Visual analytics tools that track Seres Therapeutics Inc. performanceMarket Movement Recap & Technical Confirmation Alerts - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Is Seres Therapeutics Inc. backed by strong institutional buyingTrade Analysis Report & Target Return Focused Picks - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Has Seres Therapeutics Inc. formed a bullish divergenceJuly 2025 News Drivers & Proven Capital Preservation Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Volume spikes in Seres Therapeutics Inc. stock – what they mean2025 Sector Review & Safe Entry Point Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Pattern recognition hints at Seres Therapeutics Inc. upsideQuarterly Growth Report & Low Drawdown Trading Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can Seres Therapeutics Inc. be the next market leaderMarket Trend Summary & High Conviction Buy Zone Picks - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Applying chart zones and confluence areas to Seres Therapeutics Inc.Weekly Volume Report & Real-Time Volume Analysis Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What candlestick patterns are forming on Seres Therapeutics Inc.Stock Surge & Safe Entry Momentum Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Why Seres Therapeutics Inc. stock attracts strong analyst attention2025 Fundamental Recap & Weekly High Momentum Picks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Seres Therapeutics Inc. subject to activist investor interestWeekly Trade Review & Detailed Earnings Play Strategies - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Seres Therapeutics Inc. stock volume spike explained2025 Volatility Report & Low Drawdown Momentum Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Earnings visualization tools for Seres Therapeutics Inc.2025 Trading Recap & Daily Stock Trend Reports - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Full technical analysis of Seres Therapeutics Inc. stockQuarterly Trade Review & Daily Growth Stock Investment Tips - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Is Seres Therapeutics Inc. Starting a New UptrendQuarterly Portfolio Report & Free High Return Stock Watch Alerts - beatles.ru

Sep 01, 2025
pulisher
Sep 01, 2025

Custom strategy builders for tracking Seres Therapeutics Inc.Quarterly Profit Summary & Daily Volume Surge Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

How to integrate Seres Therapeutics Inc. into portfolio analysis toolsWeekly Market Outlook & Entry Point Confirmation Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Advanced analytics toolkit walkthrough for Seres Therapeutics Inc.July 2025 Rallies & AI Driven Stock Reports - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Custom watchlist performance reports with Seres Therapeutics Inc.Take Profit & Reliable Price Action Trade Plans - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 12:42:02 - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Order flow analysis tools used on Seres Therapeutics Inc.2025 Earnings Impact & Low Volatility Stock Recommendations - Newser

Aug 31, 2025

Seres Therapeutics Inc (MCRB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Seres Therapeutics Inc (MCRB) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
DesRosier Thomas
See Remarks
Aug 18 '25
Sale
16.65
76
1,265
7,455
Henn Matthew R
See Remarks
Aug 18 '25
Sale
16.65
73
1,215
4,548
Young Teresa L.
See Remarks
Aug 18 '25
Sale
16.65
59
982
5,215
Young Teresa L.
See Remarks
May 16 '25
Sale
7.28
63
459
5,044
Shaff Eric D.
CEO and President
May 16 '25
Sale
7.28
220
1,602
10,102
DesRosier Thomas
Chief Legal Officer and EVP
May 15 '25
Sale
7.28
79
575
7,287
Henn Matthew R
See Remarks
May 16 '25
Sale
7.28
77
561
4,383
Young Teresa L.
See Remarks
Feb 18 '25
Sale
0.81
3,338
2,704
97,536
Henn Matthew R.
See Remarks
Feb 18 '25
Sale
0.81
3,953
3,204
84,443
Shaff Eric D.
CEO and President
Feb 18 '25
Sale
0.81
12,726
10,314
192,039
$85.63
price down icon 1.55%
$27.25
price up icon 0.63%
$23.71
price up icon 1.06%
$100.17
price down icon 0.26%
$141.87
price down icon 1.10%
biotechnology ONC
$319.92
price down icon 4.86%
大文字化:     |  ボリューム (24 時間):